B Tex Ointment Manufacturing Company Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.12 M
- Company Age 47 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 212.86%
- Profit Growth 138.63%
- Ebitda 9.60%
- Net Worth 1.04%
- Total Assets 1.04%
About B Tex Ointment Manufacturing Company
B Tex Ointment Manufacturing Company Private Limited (BTOMCPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 June 1977 and has a history of 47 years and eight months. Its registered office is in Navsari, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Sejalben Patel and Ajay Patel serve as directors at the Company.
Company Details
- Location
Navsari, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299GJ1977PTC003012
- Company No.
003012
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 1977
- Date of AGM
10 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at B Tex Ointment Manufacturing Company?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sejalben Patel  | Director | 16-Jan-2008 | Current |
| Ajay Patel | Director | 09-Apr-1992 | Current |
Financial Performance of B Tex Ointment Manufacturing Company.
B Tex Ointment Manufacturing Company Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 212.86% increase. The company also saw a substantial improvement in profitability, with a 138.63% increase in profit. The company's net worth moved up by a moderate rise of 1.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B Tex Ointment Manufacturing Company?
In 2023, B Tex Ointment Manufacturing Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Daiwik Pharmasphere Private LimitedAjay Patel is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at B Tex Ointment Manufacturing Company?
Unlock and access historical data on people associated with B Tex Ointment Manufacturing Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B Tex Ointment Manufacturing Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B Tex Ointment Manufacturing Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.